Mallinckrodt and Endo announced that their respective shareholders have provided the necessary shareholder approvals for the companies to combine in a stock and cash transaction that will create a ...

CHICAGO — The combination of IV bimagrumab and subcutaneous semaglutide was linked to large reductions in body weight and fat mass at 72 weeks with no serious impact on lean mass, according ...

AbbVie's Phase 3 VERONA trial in HR-MDS showed no overall survival benefit for venetoclax-azacitidine; existing uses of venetoclax remain unchanged.

Luigi Lavazza SpA is studying a tie-up with Germany’s Dallmayr as the coffee industry remains under pressure due to surging prices, Corriere della Sera reported on Saturday, without saying where ...

New results for Johnson & Johnson's bleximenib demonstrate promising antileukemic activity in combination with venetoclax and azacitidine for acute myeloid leukemia ...

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV treatments due to low levels of a type of white blood cell in some ...

Telecommunications industry officials have determined that the 912 area code will exhaust its potential combinations by the second quarter of 2028 ...

'The completion of this transaction marks a transformational step for XCF Global and the decarbonization of the aviation industry', XCF Global CEO Mihir Dange said.

Combination therapy shows superior efficacy in reducing albumin in chronic kidney disease and type 2 diabetes patients by European Renal Association ...

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if backed by outcomes, herald a “new age” of care, suggests a ...

Key takeaways: The addition of relacorilant to nab-paclitaxel reduced risk for progression or death by 30% among women with platinum-resistant disease. The combination is a potential new standard ...

Combination therapy can prolong life in severe heart disease Aortic stenosis and concomitant cardiac amyloidosis should be treated together Date: June 2, 2025 Source: Medical University of Vienna ...